Pearl Pathways is excited to add Patti Hunker to their team as the senior leader in clinical research and management of foundation as Clinical Research Advisor. Hunker has over 10 years of clinical research experience in both drug and device trials. Previously, she...
Stan Collender, a cancer patient, shares an interesting New York Times op ed piece on why so few cancer patients participate in clinical trials. Stan is a diagnosed with Merkel cell carcinoma (a rare skin cancer) and is enrolled in a clinical trial with, in his...
Pearl Pathways has expanded and is thrilled to announce its hiring of John Lockwood as their new Regulatory Compliance Advisor. Lockwood has over 20 years of experience in quality, regulatory, auditing, and purchasing roles in the life sciences industry. In addition...
Link Indiana is the newest creation from the Indiana Small Business Development Center (ISBDC). Link Indiana is one of the many ways ISBDC is trying promote their mission of encouraging direction and networking for all small businesses. Link Indiana is for all small...
Recently the National Cancer Institute (NCI) promoted its deputy director, Doug Lowry, to director with the sudden resignation of Harold Varmus, MD. Not only has the NCI been managing through the transition with a new director, it also has been dealing with new budget...
